nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—Cholelithiasis—Octreotide—thymus cancer	0.0272	0.0463	CcSEcCtD
Fludarabine—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.0248	0.0423	CcSEcCtD
Fludarabine—POLA1—hematopoietic system—thymus cancer	0.0236	0.0589	CbGeAlD
Fludarabine—Herpes zoster—Octreotide—thymus cancer	0.0225	0.0383	CcSEcCtD
Fludarabine—SLC28A3—bone marrow—thymus cancer	0.0215	0.0538	CbGeAlD
Fludarabine—Numbness—Octreotide—thymus cancer	0.0204	0.0348	CcSEcCtD
Fludarabine—Sensory loss—Octreotide—thymus cancer	0.0195	0.0333	CcSEcCtD
Fludarabine—SLC28A3—lung—thymus cancer	0.0195	0.0487	CbGeAlD
Fludarabine—RRM1—hematopoietic system—thymus cancer	0.0187	0.0468	CbGeAlD
Fludarabine—Hearing impaired—Octreotide—thymus cancer	0.0178	0.0303	CcSEcCtD
Fludarabine—POLA1—pituitary gland—thymus cancer	0.0175	0.0437	CbGeAlD
Fludarabine—Hyperkalaemia—Octreotide—thymus cancer	0.0166	0.0283	CcSEcCtD
Fludarabine—SLC29A1—hematopoietic system—thymus cancer	0.0152	0.038	CbGeAlD
Fludarabine—POLA1—bone marrow—thymus cancer	0.0151	0.0378	CbGeAlD
Fludarabine—POLA1—thyroid gland—thymus cancer	0.0151	0.0377	CbGeAlD
Fludarabine—DCK—hematopoietic system—thymus cancer	0.0145	0.0363	CbGeAlD
Fludarabine—Phlebitis—Octreotide—thymus cancer	0.0143	0.0243	CcSEcCtD
Fludarabine—RRM1—cardiac atrium—thymus cancer	0.0142	0.0355	CbGeAlD
Fludarabine—Sleep disorder—Octreotide—thymus cancer	0.0142	0.0242	CcSEcCtD
Fludarabine—RRM1—pituitary gland—thymus cancer	0.0139	0.0347	CbGeAlD
Fludarabine—Deafness—Octreotide—thymus cancer	0.0137	0.0234	CcSEcCtD
Fludarabine—POLA1—lung—thymus cancer	0.0137	0.0342	CbGeAlD
Fludarabine—Cardiac failure congestive—Octreotide—thymus cancer	0.0135	0.0231	CcSEcCtD
Fludarabine—RRM1—lymphoid tissue—thymus cancer	0.0132	0.0329	CbGeAlD
Fludarabine—Visual disturbance—Octreotide—thymus cancer	0.013	0.0221	CcSEcCtD
Fludarabine—Adenosine triphosphate—AKT1—thymus cancer	0.0125	1	CrCbGaD
Fludarabine—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.0123	0.0209	CcSEcCtD
Fludarabine—RRM1—bone marrow—thymus cancer	0.012	0.03	CbGeAlD
Fludarabine—RRM1—thyroid gland—thymus cancer	0.012	0.0299	CbGeAlD
Fludarabine—SLC29A1—cardiac atrium—thymus cancer	0.0116	0.0289	CbGeAlD
Fludarabine—Dehydration—Octreotide—thymus cancer	0.0114	0.0195	CcSEcCtD
Fludarabine—SLC29A1—pituitary gland—thymus cancer	0.0113	0.0282	CbGeAlD
Fludarabine—DCK—cardiac atrium—thymus cancer	0.011	0.0276	CbGeAlD
Fludarabine—RRM1—lung—thymus cancer	0.0109	0.0272	CbGeAlD
Fludarabine—DCK—pituitary gland—thymus cancer	0.0108	0.0269	CbGeAlD
Fludarabine—SLC29A1—lymphoid tissue—thymus cancer	0.0107	0.0268	CbGeAlD
Fludarabine—Sweating increased—Octreotide—thymus cancer	0.0103	0.0176	CcSEcCtD
Fludarabine—DCK—lymphoid tissue—thymus cancer	0.0102	0.0256	CbGeAlD
Fludarabine—Bronchitis—Octreotide—thymus cancer	0.0102	0.0174	CcSEcCtD
Fludarabine—Dysuria—Octreotide—thymus cancer	0.00992	0.0169	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Octreotide—thymus cancer	0.00986	0.0168	CcSEcCtD
Fludarabine—SLC29A1—bone marrow—thymus cancer	0.00976	0.0244	CbGeAlD
Fludarabine—SLC29A1—thyroid gland—thymus cancer	0.00974	0.0243	CbGeAlD
Fludarabine—Hyperglycaemia—Octreotide—thymus cancer	0.00957	0.0163	CcSEcCtD
Fludarabine—Pneumonia—Octreotide—thymus cancer	0.00952	0.0162	CcSEcCtD
Fludarabine—POLA1—lymph node—thymus cancer	0.00937	0.0234	CbGeAlD
Fludarabine—DCK—bone marrow—thymus cancer	0.00933	0.0233	CbGeAlD
Fludarabine—DCK—thyroid gland—thymus cancer	0.0093	0.0232	CbGeAlD
Fludarabine—Neuropathy peripheral—Octreotide—thymus cancer	0.00927	0.0158	CcSEcCtD
Fludarabine—Urinary tract infection—Octreotide—thymus cancer	0.0092	0.0157	CcSEcCtD
Fludarabine—Haematuria—Octreotide—thymus cancer	0.00902	0.0154	CcSEcCtD
Fludarabine—Epistaxis—Octreotide—thymus cancer	0.00892	0.0152	CcSEcCtD
Fludarabine—Sinusitis—Octreotide—thymus cancer	0.00888	0.0151	CcSEcCtD
Fludarabine—SLC29A1—lung—thymus cancer	0.00884	0.0221	CbGeAlD
Fludarabine—Hypoaesthesia—Octreotide—thymus cancer	0.00845	0.0144	CcSEcCtD
Fludarabine—DCK—lung—thymus cancer	0.00845	0.0211	CbGeAlD
Fludarabine—Pharyngitis—Octreotide—thymus cancer	0.00843	0.0144	CcSEcCtD
Fludarabine—Visual impairment—Octreotide—thymus cancer	0.00819	0.0139	CcSEcCtD
Fludarabine—Arrhythmia—Octreotide—thymus cancer	0.00759	0.0129	CcSEcCtD
Fludarabine—Alopecia—Octreotide—thymus cancer	0.00751	0.0128	CcSEcCtD
Fludarabine—RRM1—lymph node—thymus cancer	0.00744	0.0186	CbGeAlD
Fludarabine—Malnutrition—Octreotide—thymus cancer	0.00739	0.0126	CcSEcCtD
Fludarabine—Ill-defined disorder—Octreotide—thymus cancer	0.00686	0.0117	CcSEcCtD
Fludarabine—Anaemia—Octreotide—thymus cancer	0.00683	0.0116	CcSEcCtD
Fludarabine—Agitation—Octreotide—thymus cancer	0.00679	0.0116	CcSEcCtD
Fludarabine—Malaise—Octreotide—thymus cancer	0.00667	0.0114	CcSEcCtD
Fludarabine—Cough—Octreotide—thymus cancer	0.00645	0.011	CcSEcCtD
Fludarabine—Convulsion—Octreotide—thymus cancer	0.00641	0.0109	CcSEcCtD
Fludarabine—Arthralgia—Octreotide—thymus cancer	0.00629	0.0107	CcSEcCtD
Fludarabine—Myalgia—Octreotide—thymus cancer	0.00629	0.0107	CcSEcCtD
Fludarabine—Discomfort—Octreotide—thymus cancer	0.00622	0.0106	CcSEcCtD
Fludarabine—SLC29A1—lymph node—thymus cancer	0.00605	0.0151	CbGeAlD
Fludarabine—Anaphylactic shock—Octreotide—thymus cancer	0.00603	0.0103	CcSEcCtD
Fludarabine—Oedema—Octreotide—thymus cancer	0.00603	0.0103	CcSEcCtD
Fludarabine—Infection—Octreotide—thymus cancer	0.006	0.0102	CcSEcCtD
Fludarabine—Nervous system disorder—Octreotide—thymus cancer	0.00592	0.0101	CcSEcCtD
Fludarabine—Thrombocytopenia—Octreotide—thymus cancer	0.00591	0.0101	CcSEcCtD
Fludarabine—Hyperhidrosis—Octreotide—thymus cancer	0.00583	0.00994	CcSEcCtD
Fludarabine—DCK—lymph node—thymus cancer	0.00578	0.0144	CbGeAlD
Fludarabine—Anorexia—Octreotide—thymus cancer	0.00575	0.0098	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.0055	0.00937	CcSEcCtD
Fludarabine—Paraesthesia—Octreotide—thymus cancer	0.00542	0.00923	CcSEcCtD
Fludarabine—Dyspnoea—Octreotide—thymus cancer	0.00538	0.00916	CcSEcCtD
Fludarabine—Dyspepsia—Octreotide—thymus cancer	0.00531	0.00905	CcSEcCtD
Fludarabine—Decreased appetite—Octreotide—thymus cancer	0.00525	0.00894	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00521	0.00887	CcSEcCtD
Fludarabine—Fatigue—Octreotide—thymus cancer	0.0052	0.00886	CcSEcCtD
Fludarabine—Constipation—Octreotide—thymus cancer	0.00516	0.00879	CcSEcCtD
Fludarabine—Pain—Octreotide—thymus cancer	0.00516	0.00879	CcSEcCtD
Fludarabine—Feeling abnormal—Octreotide—thymus cancer	0.00497	0.00847	CcSEcCtD
Fludarabine—Body temperature increased—Octreotide—thymus cancer	0.00477	0.00813	CcSEcCtD
Fludarabine—Hypersensitivity—Octreotide—thymus cancer	0.00445	0.00757	CcSEcCtD
Fludarabine—Asthenia—Octreotide—thymus cancer	0.00433	0.00738	CcSEcCtD
Fludarabine—Pruritus—Octreotide—thymus cancer	0.00427	0.00727	CcSEcCtD
Fludarabine—Diarrhoea—Octreotide—thymus cancer	0.00413	0.00703	CcSEcCtD
Fludarabine—Vomiting—Octreotide—thymus cancer	0.00384	0.00654	CcSEcCtD
Fludarabine—Rash—Octreotide—thymus cancer	0.0038	0.00648	CcSEcCtD
Fludarabine—Dermatitis—Octreotide—thymus cancer	0.0038	0.00648	CcSEcCtD
Fludarabine—Headache—Octreotide—thymus cancer	0.00378	0.00644	CcSEcCtD
Fludarabine—Nausea—Octreotide—thymus cancer	0.00358	0.00611	CcSEcCtD
